Google has invested $3.9 million in PharmaSecure, a mobile application used to verify medication authenticity using text messaging.
Researchers from Kitasato UniversitySchool of Medicine in Japan found that combining intravenous methylprednisolone pulse and intravenous immunoglobulin to treat patients with Kawasaki disease appears safe and effective.
The U.S. Food and Drug Administration has approved Pfizer’s Prevnar 13 for use in adults 50 years and older.
On March 16, 2012, H&P Industries Inc. voluntarily recalled all lots of povidine iodine prep pads.
An additional, more specific test on human serum or plasma specimens found to be positive for antibodies to Trypanosoma cruzi (T. cruzi) has been approved by the U.S. Food and Drug Administration.
Nearly 4,500 organizations — including more than 2,000 hospitals — have pledged their support for Partnership for Patients.
The U.S. Food and Drug Administration has approved the first vaccine that protects against four strains of the common flu.
A number of studies have examined the impact of plasmaderived or recombinant factor VIII (FVIII) replacement therapy on inhibitor antibody development in hemophilia A patients, with conflicting results.
Human albumin is known to exert a neuroprotective effect in animal models of cerebral ischemia and humans with various intracranial pathologies.
Canadian scientists are working on an intravenous treatment for Alzheimer’s that could halt the progression of the disease and improve cognitive functions.
A recent study shows that specific autoantibodies found in a modest proportion of mothers with an autistic child may provide more evidence of an immune component related to autism.
On July 27, 2011, Royce Lamberth, chief judge of the District of Columbia District Court, ruled that the U.S. government can continue funding embryonic stem-cell research.